Class IITerminatedD-0288-2021
Drug recall · March 3, 2021
Fludeoxyglucose F 18 Injection recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50
- Lots / codes
Lot # P01-021721, exp 02/17/2021
- Quantity
- 50 mL vial
- Company
- The General Hospital Corporation, Boston, MA
- Distribution
- Product was distributed to one direct account.
- Initiated
- February 17, 2021 · Voluntary: Firm initiated
- Classified
- February 24, 2021
- Reported
- March 3, 2021
- Ended
- March 26, 2021
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.